Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported Prepaid Assets of $1.1 million for Q1 2026, up 150.22% on a YoY basis from $452000.0 in Q1 2025, and down 80.88% quarter-over-quarter from $5.9 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 150.22% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 150.22% YoY), and the FY2025 full-year result was $5.9 million, up 1071.49% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.1 million, down from $5.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $23.6 million in Q2 2024, with the low at $452000.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $5.7 million across 5 years, with a median of $4.3 million in 2022.
- The largest YoY upside for Prepaid Assets was 1071.49% in 2025 against a maximum downside of 96.71% in 2025.
- Catalyst Pharmaceuticals' Prepaid Assets stood at $5.2 million in 2022, then sank by 74.22% to $1.3 million in 2023, then plunged by 62.09% to $505000.0 in 2024, then surged by 1071.49% to $5.9 million in 2025, then sank by 80.88% to $1.1 million in 2026.
- The last three Prepaid Assets figures came in at $1.1 million (Q1 2026), $5.9 million (Q4 2025), and $540000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.84 Bn | 3.08 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 505,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 23.55 Mn |
| Mar 31, 2024 | 13.75 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 13.96 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 6.93 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 4.43 Mn |
| Jun 30, 2021 | 7.64 Mn |